Month: May 2021

Here is today’s COVID-19 update from the County Health and Human Services Agency with data through May 26. Vaccination Progress: Doses delivered: More than 4.09 million. Doses administered: Over 3.61 million. Received at least one shot: More than 1.92 million or 68.5% of San Diegans 12 and older. Fully vaccinated: Over 1.49 million or 53.4%. The goal: fully vaccinate 75% of San Diego County residents 12 and older or 2,101,936 people. To date, 91.4% of the goal population has received at least one vaccine and 71.3% are fully vaccinated. More vaccination information can be found coronavirus-sd.com/vaccine. State Metrics: San Diego County’s state-calculated, adjusted case rate is currently 2.4 cases per 100,000 residents, placing the County in the Orange Tier. The testing posi...

The leader of the House Freedom Caucus is asking the head of the Centers for Disease Control and Prevention (CDC) whether House Speaker Nancy Pelosi, D-Calif., consulted with the scientists before continuing the coronavirus mask mandate in the House chamber.  Rep. Andy Biggs, R-Ariz., penned a letter to Dr. Rochelle Walensky Thursday asking just one question: Did Pelosi or the Capitol physician consult with her or anyone at the CDC prior to extending the House mask mandate and social distancing protocols on May 14? "It is imperative that the American people know that their elected leaders, particularly the Speaker of the House, are making public policy decisions based on the evidence, not conjecture or what is in their political interests," Biggs wrote.  PELOSI DITCHES MASK AT WHITE H...

WASHINGTON—The Food and Drug Administration and vaccine maker Johnson & Johnson JNJ -0.15% expect to announce within days that contamination problems at a Covid-19 vaccine plant in Baltimore are resolved, clearing the way for millions more doses to become available. Vaccine production at the plant run by contract manufacturer Emergent BioSolutions Inc. EBS 0.61% was halted after unsanitary conditions led to contamination of J&J vaccines. The facility made vaccine substance and finished vaccine doses for J&J and AstraZeneca AZN 0.62% PLC. Emergent chief executive Robert Kramer told a House co...

WASHINGTON—The Food and Drug Administration and vaccine maker Johnson & Johnson JNJ -0.15% expect to announce within days that contamination problems at a Covid-19 vaccine plant in Baltimore are resolved, clearing the way for millions more doses to become available. Vaccine production at the plant run by contract manufacturer Emergent BioSolutions Inc. EBS 0.61% was halted after unsanitary conditions led to contamination of J&J vaccines. The facility made vaccine substance and finished vaccine doses for J&J and AstraZeneca AZN 0.62% PLC. Emergent chief executive Robert Kramer told a House co...

WASHINGTON—The Food and Drug Administration and vaccine maker Johnson & Johnson expect to announce within days that contamination problems at a Covid-19 vaccine plant in Baltimore are resolved, clearing the way for millions more doses to become available. Vaccine production at the plant run by contract manufacturer Emergent BioSolutions Inc. was halted after unsanitary conditions led to contamination of J&J vaccines. The facility made vaccine substance and finished vaccine doses for J&J and AstraZeneca PLC. Emergent chief executive Robert Kramer told a House committee last week that the company had produced enough of a key ingredient to yield more than 100 million doses of the J&J vaccine. The company has been taking correc...

WASHINGTON—The Food and Drug Administration and vaccine maker Johnson & Johnson expect to announce within days that contamination problems at a Covid-19 vaccine plant in Baltimore are resolved, clearing the way for millions more doses to become available. Vaccine production at the plant run by contract manufacturer Emergent BioSolutions Inc. was halted after unsanitary conditions led to contamination of J&J vaccines. The facility made vaccine substance and finished vaccine doses for J&J and AstraZeneca PLC. Emergent chief executive Robert Kramer told a House committee last week that the company had produced enough of a key ingredient to yield more than 100 million doses of the J&J vaccine. The company has been taking correc...

WASHINGTON—The Food and Drug Administration and vaccine maker Johnson & Johnson expect to announce within days that contamination problems at a Covid-19 vaccine plant in Baltimore are resolved, clearing the way for millions more doses to become available. Vaccine production at the plant run by contract manufacturer Emergent BioSolutions Inc. was halted after unsanitary conditions led to contamination of J&J vaccines. The facility made vaccine substance and finished vaccine doses for J&J and AstraZeneca PLC. Emergent chief executive Robert Kramer told a House committee last week that the company had produced enough of a key ingredient to yield more than 100 million doses of the J&J vaccine. The company has been taking correc...